Skip to main content
logo
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.050
-0.040 (-1.91%)
At close: Jul 28, 2026, 4:00 PM EDT
2.060
+0.010 (0.51%)
After-hours: Jul 28, 2026, 5:24 PM EDT

Century Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-109.166.592.245.2-
Revenue Growth
-1556.76%194.81%-57.01%--
Gross Profit
-109.166.592.245.2-
Selling, General & Admin
22.182433.1634.7131.8619.24
Research & Development
86.1995.67107.2492.7197.1775.65
Other Operating Expenses
-6.764.3321.3710-
Total Operating Expenses
108.36126.43144.73148.78139.0394.88
Operating Income
-115.12-17.27-138.14-146.55-133.83-94.88
Interest Income
6.947.3513.0112.684.42-
Interest Expense
----0.54-1.43-1.28
Total Non-Operating Income (Expense)
7.177.6213.3611.752.99-0.9
Pretax Income
-86.2-9.65-124.78-134.79-130.84-95.78
Provision for Income Taxes
0.070.07-1.791.880.090.04
Net Income
-107.78-9.58-126.57-136.67-130.93-95.82
Net Income to Common
-107.78-9.58-126.57-136.67-130.93-95.82
Net Income Growth
------
Shares Outstanding (Basic)
1138779595832
Shares Outstanding (Diluted)
1138779595832
Shares Change
34.04%10.05%32.60%2.70%78.30%332.95%
EPS (Basic)
-1.14-0.14-1.61-2.30-2.27-2.96
EPS (Diluted)
-1.14-0.14-1.61-2.30-2.27-2.96
EPS Growth
------
Free Cash Flow
-95.47-104.72-110.29-102.08-16.55-133.97
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.84-1.21-1.40-1.72-0.29-4.14
Gross Margin
-100.00%100.00%100.00%100.00%-
Operating Margin
--15.82%-2096.48%-6556.87%-2574.17%-
Profit Margin
--8.78%-1920.87%-6115.12%-2518.41%-
FCF Margin
--95.93%-1673.84%-4567.52%-318.37%-
EBITDA
-102.24-4.17-124.83-133.5-125.39-91.14
EBITDA Margin
--3.82%-1894.57%-5973.24%-2411.83%-
EBIT
-115.12-17.27-138.14-146.55-133.83-94.88
EBIT Margin
--15.82%-2096.48%-6556.87%-2574.17%-
Effective Tax Rate
-0.08%-0.70%1.43%-1.40%-0.07%-0.04%
SEC Filings: 10-K · 10-Q